News Related News

Amyris Partners with Queensland on Biofutures Acceleration Program in Next Step Toward Planned Development of Biorefinery

EMERYVILLE, Calif. and BRISBANE, Australia, June 20, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and the Government of Queensland, Australia today announced the next step their plans to develop a leading industrial biotechnology hub in Southeast [...]

Novel Biomaterial That Filters Out Harmful Micropollutants Wins Science Award

20 June 2017- A granular adsorbent capable of the specific binding and removing of target micro-pollutants, including pesticides, pharmaceuticals, high performance chemicals and heavy metals, from wastewater has won a prestigious materials science award. This adsorbent will be particularly relevant [...]

Second Microbial and Plant Systems Modulated by Secondary Metabolite Meeting – Joint Genome Institute

The US. Department of Energy Joint Genome Institute is hosting the second Microbial and Plant Systems Modulated by Secondary Metabolite Meeting, July 24-26 in Walnut Creek California. The meeting will bring together a diverse group of investigators interested in the [...]

By | June 20th, 2017|News|

Intellia Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China

CAMBRIDGE, Mass., June 19, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics (NASDAQ: NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR technology, today announced that China’s State Intellectual Property Office (“SIPO”) has indicated that [...]

By | June 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China

BASEL, Switzerland, June 19, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced that China’s State Intellectual Property Office (“SIPO”) has granted a patent broadly covering CRISPR’s in-licensed gene [...]

By | June 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Dr. Una Ryan Joins Elemental Machines Board of Directors

June 15, 2017 09:00 AM Eastern Daylight Time CAMBRIDGE, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Elemental Machines today announced that the distinguished Dr. Una Ryan, OBE has joined its Board of Directors. Bringing more than 50 years of experience to this role, Ryan [...]